We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Are we on the same page when it comes to TED?
Program Chair Prem S. Subramanian, MD, PhD, and an expert panel of oculoplastic surgeons, neuro-ophthalmologists, endocrinologists, and comprehensive ophthalmologists address this question and delve into the contentious and evolving landscape of TED management. Watch this dynamic multidisciplinary dialogue that will explore the associated challenges, controversies, and practice patterns of TED, as well as the intricacies of TED treatment.
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Prem S. Subramanian, MD, PhD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acelyrin, Alexion, GenSight Biologics, Horizon Therapeutics, Invex Therapeutics, Kriya Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics. Grant/Research Support: Department of Defense, Horizon Therapeutics, and National Institutes of Health. Independent Contractor: GenSight Biologics, Horizon Therapeutics, Immunovant, Invex Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics.
Raymond Cho, MD, FACS, has had no financial relationships or affiliations with ineligible companies.
Sonalika Khachikian, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen and Amneal Pharmaceuticals. Speaker's Bureau: Amgen.
Christian Nasr, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon Therapeutics and Nevro Corp.
Lisa M. Nijm, MD, JD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Azura Ophthalmics, Bausch + Lomb, BVI Medical, Carl Zeiss Meditec, Centricity Vision, Dompe, Harrow, Horizon Therapeutics, Iveric Bio, Johnson & Johnson Vision, Nordic Pharma, Ocular Therapeutix, Orasis, Rayner, Scope Health, Sun Ophthalmics, Tarsus, Théa, TruKera Medical, Viatris, and Visus Therapeutics. Speaker's Bureau: Allergan, Bausch + Lomb, Horizon Therapeutics, Johnson & Johnson Vision, Ocular Therapeutix, Sun Ophthalmics, and Viatris. Grant/Research Support: Ocular Therapeutix. Stock Options: TruKera Medical.
Madhura Tamhankar, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Genentech, and Viridian Therapeutics.
Sara Tullis Wester, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon, Immunovant, Lassen, and Vasaragen/Sling. Grant/Research Support: Horizon, Immunovant, and Vasaragen/Sling.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Upon completion of this activity, the participant should be able to:
This certified continuing education activity is designed for oculoplastic surgeons, endocrinologists, neuro-ophthalmologists, and comprehensive ophthalmologists involved in the care of patients with thyroid eye disease.
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.
This activity is supported by an independent educational grant from Amgen.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
A Multidisciplinary Exploration of Complexities and Controversies in Thyroid Eye Disease: Spotlight on Diagnosis
Show moreAre we on the same page when it comes to TED?
Program Chair Prem S. Subramanian, MD, PhD, and an expert panel of oculoplastic surgeons, neuro-ophthalmologists, endocrinologists, and comprehensive ophthalmologists address this question and delve into the contentious and evolving landscape of TED management. Watch this dynamic multidisciplinary dialogue that will explore the associated challenges, controversies, and practice patterns of TED, as well as the intricacies of TED treatment.
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Prem S. Subramanian, MD, PhD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acelyrin, Alexion, GenSight Biologics, Horizon Therapeutics, Invex Therapeutics, Kriya Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics. Grant/Research Support: Department of Defense, Horizon Therapeutics, and National Institutes of Health. Independent Contractor: GenSight Biologics, Horizon Therapeutics, Immunovant, Invex Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics.
Raymond Cho, MD, FACS, has had no financial relationships or affiliations with ineligible companies.
Sonalika Khachikian, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen and Amneal Pharmaceuticals. Speaker's Bureau: Amgen.
Christian Nasr, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon Therapeutics and Nevro Corp.
Lisa M. Nijm, MD, JD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Azura Ophthalmics, Bausch + Lomb, BVI Medical, Carl Zeiss Meditec, Centricity Vision, Dompe, Harrow, Horizon Therapeutics, Iveric Bio, Johnson & Johnson Vision, Nordic Pharma, Ocular Therapeutix, Orasis, Rayner, Scope Health, Sun Ophthalmics, Tarsus, Théa, TruKera Medical, Viatris, and Visus Therapeutics. Speaker's Bureau: Allergan, Bausch + Lomb, Horizon Therapeutics, Johnson & Johnson Vision, Ocular Therapeutix, Sun Ophthalmics, and Viatris. Grant/Research Support: Ocular Therapeutix. Stock Options: TruKera Medical.
Madhura Tamhankar, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Genentech, and Viridian Therapeutics.
Sara Tullis Wester, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon, Immunovant, Lassen, and Vasaragen/Sling. Grant/Research Support: Horizon, Immunovant, and Vasaragen/Sling.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Upon completion of this activity, the participant should be able to:
This certified continuing education activity is designed for oculoplastic surgeons, endocrinologists, neuro-ophthalmologists, and comprehensive ophthalmologists involved in the care of patients with thyroid eye disease.
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.
This activity is supported by an independent educational grant from Amgen.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
A Multidisciplinary Exploration of Complexities and Controversies in Thyroid Eye Disease: Spotlight on Diagnosis
Show moreStay current with the best on medical education
